FIM
Fernwood Investment Management Portfolio holdings
AUM
$288M
This Quarter Return
+6.76%
1 Year Return
+33.53%
3 Year Return
+83.32%
5 Year Return
+196.78%
10 Year Return
+650.37%
AUM
$187M
AUM Growth
+$187M
(+17%)
Cap. Flow
+$19.7M
Cap. Flow
% of AUM
10.53%
Top 10 Holdings %
Top 10 Hldgs %
34.89%
Holding
157
New
19
Increased
35
Reduced
66
Closed
8
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$5.83M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$2.94M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
$2.59M |
| 4 |
iShares Russell 1000 ETF
IWB
|
$2.46M |
| 5 |
iShares Select Dividend ETF
DVY
|
$2.19M |
Top Sells
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$2.32M |
| 2 |
Safety Insurance
SAFT
|
$458K |
| 3 |
Teva Pharmaceuticals
TEVA
|
$319K |
| 4 |
STON
StoneMor Inc.
STON
|
$314K |
| 5 |
MACOM Technology Solutions
MTSI
|
$272K |
Sector Composition
| 1 | Healthcare | 28.74% |
| 2 | Energy | 8.15% |
| 3 | Consumer Staples | 6.41% |
| 4 | Technology | 6.23% |
| 5 | Financials | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.1M | 7.56% | 359,094 -58,916 | -14% | -$2.32M |
|
|
MYOK
2
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $11.1M | 5.95% | 264,454 +18,072 | +7% | +$761K |
|
|
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $11.1M | 5.95% | 228,577 -1,000 | -0.4% | -$48.7K |
|
|
4
iShares Core S&P 500 ETF
IVV
$662B
| $5.83M | 3.12% | +21,670 | New | +$5.83M |
|
5
Altria Group
MO
$113B
| $5M | 2.67% | 69,944 +700 | +1% | +$50K |
|
6
Meta Platforms (Facebook)
META
$1.86T
| $4.27M | 2.29% | 24,213 -270 | -1% | -$47.6K |
|
7
iShares US Consumer Staples ETF
IYK
$1.35B
| $3.75M | 2.01% | 29,590 -302 | -1% | -$38.3K |
|
8
Gilead Sciences
GILD
$140B
| $3.53M | 1.89% | 49,243 -2,790 | -5% | -$200K |
|
9
CVS Health
CVS
$92.8B
| $3.4M | 1.82% | 46,873 -1,600 | -3% | -$116K |
|
10
Biogen
BIIB
$19.4B
| $3.08M | 1.65% | 9,675 -225 | -2% | -$71.7K |
|
|
11
iShares Select Dividend ETF
DVY
$20.8B
| $3.05M | 1.63% | 30,960 +22,216 | +254% | +$2.19M |
|
12
Philip Morris
PM
$260B
| $2.97M | 1.59% | 28,083 +1,041 | +4% | +$110K |
|
|
13
iShares Russell 2000 ETF
IWM
$67B
| $2.94M | 1.57% | +19,291 | New | +$2.94M |
|
14
Iron Mountain
IRM
$27.3B
| $2.74M | 1.47% | 72,708 -2,054 | -3% | -$77.5K |
|
15
Johnson & Johnson
JNJ
$427B
| $2.74M | 1.47% | 19,623 -200 | -1% | -$27.9K |
|
16
Visa
V
$683B
| $2.65M | 1.42% | 23,262 +295 | +1% | +$33.6K |
|
|
17
iShares Core S&P Mid-Cap ETF
IJH
$100B
| $2.59M | 1.38% | +13,635 | New | +$2.59M |
|
|
18
iShares Russell 1000 ETF
IWB
$43.2B
| $2.46M | 1.31% | +16,529 | New | +$2.46M |
|
19
Apple
AAPL
$3.45T
| $2.44M | 1.3% | 14,393 +1,620 | +13% | +$274K |
|
20
Union Pacific
UNP
$133B
| $2.42M | 1.3% | 18,060 -600 | -3% | -$80.5K |
|
21
Golar LNG
GLNG
$4.48B
| $2.39M | 1.28% | 80,250 -600 | -0.7% | -$17.9K |
|
22
Vanguard Mega Cap Growth ETF
MGK
$28.9B
| $2.08M | 1.11% | 18,720 +129 | +0.7% | +$14.4K |
|
23
Phillips 66
PSX
$54B
| $2.03M | 1.08% | 20,051 -407 | -2% | -$41.2K |
|
24
Exxon Mobil
XOM
$487B
| $2.02M | 1.08% | 24,090 -145 | -0.6% | -$12.1K |
|
25
Weyerhaeuser
WY
$18.7B
| $2.01M | 1.07% | 56,970 -2,050 | -3% | -$72.3K |
|